Article Versions Notes

Miolo G, Di Gregorio E, Saorin A, Lombardi D, Scalone S, Buonadonna A, Steffan A, Corona G. Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin. Cancers. 2020; 12(7):1983. https://doi.org/10.3390/cancers12071983

Miolo, Gianmaria, Emanuela Di Gregorio, Asia Saorin, Davide Lombardi, Simona Scalone, Angela Buonadonna, Agostino Steffan, and Giuseppe Corona. 2020. "Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin" Cancers 12, no. 7: 1983. https://doi.org/10.3390/cancers12071983

Miolo, G., Di Gregorio, E., Saorin, A., Lombardi, D., Scalone, S., Buonadonna, A., Steffan, A., & Corona, G. (2020). Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin. Cancers, 12(7), 1983. https://doi.org/10.3390/cancers12071983